- Article
SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism
- Jiangxue Han,
- Shunwang Li,
- Weizhi Wang,
- Xinhai Jiang,
- Chao Liu,
- Lijuan Lei,
- Yining Li,
- Ren Sheng,
- Yuyan Zhang and
- Yexiang Wu
- + 4 authors
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. Silencing information regulator 1 (SIRT1) was demonstrated to modulate cholesterol and lipid metabolism in NAFLD. Here, a novel SIRT1 activator, E1231, was studied for...

